NYSE:EVR - New York Stock Exchange, Inc. - US29977A1051 - Common Stock - Currency: USD
Based on technical and fundamental analysis of NYSE:EVR we find: EVERCORE INC - A (NYSE:EVR) qualifies as a high growth stock and is consolidating.
Yale University’s endowment is exploring sales of private equity fund stakes as Ivy League schools stare down budget challenges stemming from lackluster investment performance and pressure from President Donald Trump.
Charles Schwab (SCHW) delivered earnings and revenue surprises of 4% and 1.48%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: SCHW
Evercore (EVR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Sitetracker Inc. is exploring a sale that could value the software platform for managing infrastructure assets at about $1 billion, according to people familiar with the matter.
VillageMD, the health care clinic chain backed by Walgreens Boots Alliance Inc., is working with Evercore Inc. for assistance as explores options that include a sale or restructuring of its operations, according to people with knowledge of the matter.
Mentions: WBA
Estée Lauder Cos is reviewing its portfolio of beauty brands, people with knowledge of the matter said, as the cosmetics company transitions to new leadership and looks to boost its share price.
Executives at Bausch Health Cos Inc are shaking up the company’s team of advisers as part of the latest in a years-long effort to tackle some of its approximately $20 billion dollars of debt and enable a crucial asset sale.
A group of investors being advised by Maverick Carter, Los Angeles Lakers star LeBron James’ business partner, is seeking to raise $5 billion from private capital sources to form an international basketball league to rival the National Basketball Association, according to people familiar with the matter.
Mentions: UBS